Blast count procedure

Known as: BLAST, Blast Count, blast cells 
The determination of the number of blast cells present in a blood sample.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
This study aimed to determine the incidence/prognostic impact of TP53 mutation in 318 myelodysplastic syndrome (MDS) patients… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
The impact of ten-eleven-translocation 2 (TET2) mutations on response to azacitidine (AZA) in MDS has not been reported. We… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE Azacitidine (AZA) is the current standard of care for high-risk (ie, International Prognostic Scoring System high or… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE This phase I dose-escalation trial was performed to determine the maximum-tolerated dose, dose-limiting toxicities, and… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE In a phase III randomized trial, azacitidine significantly prolonged overall survival (OS) compared with conventional… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Leukemic cells from 30% of patients with acute myeloid leukemia (AML) have an activating mutation in the FLT3 (fms-like tyrosine… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
We analyzed data of 76 consecutive patients with myelodysplastic syndrome (MDS) and isolated del(5q) (n=66) or del(5q) plus one… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
In 1982, the French-American-British (FAB) cooperative group proposed a classification of myelodysplastic syndromes (MDS) based… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Vascular endothelial growth factor (VEGF) is a potent mitogen for vascular endothelial cells. It has been associated with… (More)
  • table 1
  • figure 1
  • table 3
  • table 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Among 4,760 acute lymphoblastic leukemia (ALL) patients enrolled from 1986 to 1995 in two subsequent trials of the BFM and AIEOP… (More)
Is this relevant?